Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
- PMID: 2898299
- DOI: 10.1016/0092-8674(88)90184-5
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
Abstract
We have used transgenic mice that carry an activated c-neu oncogene driven by a mouse mammary tumor virus (MMTV) promoter to assess the stepwise progression of carcinogenesis in mammary epithelium. Unlike the stochastic occurrence of solitary mammary tumors in transgenic mice bearing the MMTV/c-myc or the MMTV/v-Ha-ras oncogenes, transgenic mice uniformly expressing the MMTV/c-neu gene develop mammary adenocarcinomas that involve the entire epithelium in each gland. Because these tumors arise synchronously and are polyclonal in origin, expression of the activated c-neu oncogene appears to be sufficient to induce malignant transformation in this tissue in a single step. In contrast, expression of the c-neu transgene in the parotid gland or epididymis leads to benign, bilateral epithelial hypertrophy and hyperplasia which does not progress to full malignant transformation during the observation period. These results indicate that the combination of activated oncogene and tissue context are major determinants of malignant progression and that expression of the activated form of c-neu in the mammary epithelium has particularly deleterious consequences.
Similar articles
-
Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene.Cell. 1989 Jun 16;57(6):931-6. doi: 10.1016/0092-8674(89)90331-0. Cell. 1989. PMID: 2567634
-
Activated neu induces rapid tumor progression.J Biol Chem. 1996 Mar 29;271(13):7673-8. doi: 10.1074/jbc.271.13.7673. J Biol Chem. 1996. PMID: 8631805
-
Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.Cell. 1987 May 22;49(4):465-75. doi: 10.1016/0092-8674(87)90449-1. Cell. 1987. PMID: 3032456
-
An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice.J Cell Biol. 1993 Jul;122(1):199-208. doi: 10.1083/jcb.122.1.199. J Cell Biol. 1993. PMID: 8100231 Free PMC article.
-
Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.Biochem Soc Symp. 1998;63:159-65. Biochem Soc Symp. 1998. PMID: 9513720 Review.
Cited by
-
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.J Exp Clin Cancer Res. 2024 Nov 5;43(1):296. doi: 10.1186/s13046-024-03213-6. J Exp Clin Cancer Res. 2024. PMID: 39497135 Free PMC article.
-
Class Effect Unveiled: PPARγ Agonists and MEK Inhibitors in Cancer Cell Differentiation.Cells. 2024 Sep 9;13(17):1506. doi: 10.3390/cells13171506. Cells. 2024. PMID: 39273076 Free PMC article.
-
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth.Vaccines (Basel). 2024 Jul 21;12(7):808. doi: 10.3390/vaccines12070808. Vaccines (Basel). 2024. PMID: 39066446 Free PMC article.
-
Genomic Deletion of PFKFB3 Decreases In Vivo Tumorigenesis.Cancers (Basel). 2024 Jun 26;16(13):2330. doi: 10.3390/cancers16132330. Cancers (Basel). 2024. PMID: 39001392 Free PMC article.
-
Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures.Clin Transl Oncol. 2024 Sep;26(9):2323-2338. doi: 10.1007/s12094-024-03472-x. Epub 2024 Apr 9. Clin Transl Oncol. 2024. PMID: 38592638
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous